All Stories

  1. Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses

    Article • Clinical Epidemiology, September 2019, Taylor & Francis

    Dr Michael Hoffmeister, Hermann Brenner, Daniel Boakye

  2. Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score

    Article • Clinical Epidemiology, January 2018, Dove Medical Press

    Dr Michael Hoffmeister

  3. Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy

    Article • Genomics, December 2015, Elsevier

    Dr Michael Hoffmeister

  4. Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment

    Article • American Journal of Clinical Nutrition, November 2015, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  5. Colorectal cancer screening: the time to act is now

    Article • BMC Medicine, October 2015, Springer Science + Business Media

    Dr Michael Hoffmeister

  6. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1

    Article • Human Genetics, September 2015, Springer Science + Business Media

    Dr Michael Hoffmeister

  7. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program

    Article • Gastroenterology, August 2015, Elsevier

    Dr Michael Hoffmeister

  8. Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: Analyses based on 4,407,971 screening colonoscopies

    Article • European Journal of Cancer, July 2015, Elsevier

    Dr Michael Hoffmeister

  9. A Model to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci

    Article • Gastroenterology, June 2015, Elsevier

    Dr Michael Hoffmeister

  10. Smoking and survival of colorectal cancer patients: Population-based study from Germany

    Article • International Journal of Cancer, May 2015, Wiley

    Dr Michael Hoffmeister

  11. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer

    Article • International Journal of Cancer, May 2015, Wiley

    Dr Michael Hoffmeister

  12. Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk

    Article • Cancer Epidemiology Biomarkers & Prevention, May 2015, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  13. Authors' reply: Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis

    Article • International Journal of Cancer, April 2015, Wiley

    Dr Michael Hoffmeister

  14. Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany

    Article • Clinical Gastroenterology and Hepatology, April 2015, Elsevier

    Dr Michael Hoffmeister

  15. Mendelian randomization study of height and risk of colorectal cancer

    Article • International Journal of Epidemiology, April 2015, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  16. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer

    Article • The Pharmacogenomics Journal, March 2015, Nature

    Dr Michael Hoffmeister

  17. Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants

    Article • JAMA, March 2015, American Medical Association (AMA)

    Dr Michael Hoffmeister

  18. Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

    Article • JNCI Journal of the National Cancer Institute, March 2015, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  19. Identification of physicians with unusual performance in screening colonoscopy databases: a Bayesian approach

    Article • Gastrointestinal Endoscopy, March 2015, Elsevier

    Dr Michael Hoffmeister

  20. Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis

    Article • International Journal of Cancer, February 2015, Wiley

    Dr Michael Hoffmeister

  21. Genetic variants of adiponectin and risk of colorectal cancer

    Article • International Journal of Cancer, December 2014, Wiley

    Dr Michael Hoffmeister

  22. Reply

    Article • Clinical Gastroenterology and Hepatology, December 2014, Elsevier

    Dr Michael Hoffmeister

  23. Suitability of Circulating miRNAs as Potential Prognostic Markers in Colorectal Cancer

    Article • Cancer Epidemiology Biomarkers & Prevention, December 2014, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  24. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition

    Article • European Journal of Cancer, November 2014, Elsevier

    Dr Michael Hoffmeister

  25. Red Meat Intake, NAT2, and Risk of Colorectal Cancer: A Pooled Analysis of 11 Studies

    Article • Cancer Epidemiology Biomarkers & Prevention, October 2014, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  26. Lymph node count and prognosis in colorectal cancer: The influence of examination quality

    Article • International Journal of Cancer, September 2014, Wiley

    Dr Michael Hoffmeister

  27. No Evidence of Gene-Calcium Interactions from Genome-Wide Analysis of Colorectal Cancer Risk

    Article • Cancer Epidemiology Biomarkers & Prevention, September 2014, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  28. Which adenomas are detected by fecal occult blood testing? A state-wide analysis from Bavaria, Germany

    Article • International Journal of Cancer, September 2014, Wiley

    Dr Michael Hoffmeister

  29. Reply

    Article • Gastroenterology, September 2014, Elsevier

    Dr Michael Hoffmeister

  30. Mutations in POLE and survival of colorectal cancer patients – link to disease stage and treatment

    Article • Cancer Medicine, August 2014, Wiley

    Dr Michael Hoffmeister

  31. Einführung eines organisierten Darmkrebs-Screenings in Deutschland: Chancen und Herausforderungen

    Article • Das Gesundheitswesen, July 2014, Thieme Publishing Group

    Dr Michael Hoffmeister

  32. Incidence of Colorectal Adenomas: Birth Cohort Analysis among 4.3 Million Participants of Screening Colonoscopy

    Article • Cancer Epidemiology Biomarkers & Prevention, July 2014, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  33. Gene-Environment Interaction Involving Recently Identified Colorectal Cancer Susceptibility Loci

    Article • Cancer Epidemiology Biomarkers & Prevention, July 2014, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  34. Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin

    Article • Pharmacogenetics and Genomics, July 2014, Wolters Kluwer Health

    Dr Michael Hoffmeister

  35. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients

    Article • International Journal of Cancer, April 2014, Wiley

    Dr Michael Hoffmeister

  36. Genome-Wide Diet-Gene Interaction Analyses for Risk of Colorectal Cancer

    Article • PLoS Genetics, April 2014, PLOS

    Dr Michael Hoffmeister

  37. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies

    Article • BMJ, April 2014, BMJ

    Dr Michael Hoffmeister

  38. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis

    Article • Annals of Oncology, March 2014, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  39. GWAS-Identified Common Variants for Obesity Are Not Associated with the Risk of Developing Colorectal Cancer

    Article • Cancer Epidemiology Biomarkers & Prevention, March 2014, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  40. Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy

    Article • Gastroenterology, March 2014, Elsevier

    Dr Michael Hoffmeister

  41. Development and Validation of a Scoring System to Identify Individuals at High Risk for Advanced Colorectal Neoplasms Who Should Undergo Colonoscopy Screening

    Article • Clinical Gastroenterology and Hepatology, March 2014, Elsevier

    Dr Michael Hoffmeister

  42. Darmkrebsfrüherkennung

    Article • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, February 2014, Springer Science + Business Media

    Dr Michael Hoffmeister

  43. Comparisons of colorectal cancer mortality between screening participants and the general population are strongly biased unless an incidence-based mortality approach is used

    Article • Journal of Clinical Epidemiology, February 2014, Elsevier

    Dr Michael Hoffmeister

  44. Stage-specific associations between beta blocker use and prognosis after colorectal cancer

    Article • Cancer, January 2014, Wiley

    Dr Michael Hoffmeister

  45. Smoking, Lower Gastrointestinal Endoscopy, and Risk for Colorectal Cancer

    Article • Cancer Epidemiology Biomarkers & Prevention, January 2014, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  46. Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study

    Article • BMC Cancer, January 2014, Springer Science + Business Media

    Dr Michael Hoffmeister

  47. Diagnostic Performance of Guaiac-Based Fecal Occult Blood Test in Routine Screening: State-Wide Analysis from Bavaria, Germany

    Article • The American Journal of Gastroenterology, December 2013, Nature

    Dr Michael Hoffmeister

  48. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results

    Article • International Journal of Cancer, December 2013, Wiley

    Dr Michael Hoffmeister

  49. Adherence to Physician Recommendations for Surveillance in Opportunistic Colorectal Cancer Screening: The Necessity of Organized Surveillance

    Article • PLoS ONE, December 2013, PLOS

    Dr Michael Hoffmeister

  50. Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality

    Article • Cancer Epidemiology, December 2013, Elsevier

    Dr Michael Hoffmeister

  51. Body Mass Index and Microsatellite Instability in Colorectal Cancer: A Population-based Study

    Article • Cancer Epidemiology Biomarkers & Prevention, October 2013, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  52. In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening

    Article • Journal of Clinical Epidemiology, October 2013, Elsevier

    Dr Michael Hoffmeister

  53. Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

    Article • PLoS ONE, September 2013, PLOS

    Dr Juul T Wijnen, Dr Michael Hoffmeister, Fernando Fernández-Bañares

  54. Genetic Predictors of Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer

    Article • Cancer Epidemiology Biomarkers & Prevention, August 2013, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  55. Inter-Physician Variation in Follow-Up Colonoscopies after Screening Colonoscopy

    Article • PLoS ONE, July 2013, PLOS

    Dr Michael Hoffmeister

  56. The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas

    Article • Cancer Letters, July 2013, Elsevier

    Dr Michael Hoffmeister

  57. Performance of additional colonoscopies and yield of neoplasms within 3 years after screening colonoscopy: a historical cohort study

    Article • Endoscopy, June 2013, Thieme Publishing Group

    Dr Michael Hoffmeister

  58. Natural History of Colorectal Adenomas: Birth Cohort Analysis Among 3.6 Million Participants of Screening Colonoscopy

    Article • Cancer Epidemiology Biomarkers & Prevention, April 2013, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  59. Colorectal cancers occurring after colonoscopy with polyp detection: Sites of polyps and sites of cancers

    Article • International Journal of Cancer, April 2013, Wiley

    Dr Michael Hoffmeister

  60. Colorectal Cancer Risk Associated with Hormone Use Varies by Expression of Estrogen Receptor- 

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  61. Darmkrebs-Screening

    Article • Therapeutische Umschau, April 2013, Hogrefe Publishing Group

    Dr Michael Hoffmeister

  62. Adverse events requiring hospitalization within 30 days after outpatient screening and nonscreening colonoscopies

    Article • Gastrointestinal Endoscopy, March 2013, Elsevier

    Dr Michael Hoffmeister

  63. Handlungstheorie

    Article • January 2013, Transcript Verlag

    Dr Michael Hoffmeister

  64. Colonoscopy and Polyp Characteristics

    Article • Annals of Internal Medicine, January 2013, American College of Physicians

    Dr Michael Hoffmeister

  65. Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study

    Article • Journal of Nutritional Science, January 2013, Cambridge University Press

    Dr Michael Hoffmeister

  66. Genome-Wide Search for Gene-Gene Interactions in Colorectal Cancer

    Article • PLoS ONE, December 2012, PLOS

    Dr Michael Hoffmeister

  67. Role of Colonoscopy and Polyp Characteristics in Colorectal Cancer After Colonoscopic Polyp Detection

    Article • Annals of Internal Medicine, August 2012, American College of Physicians

    Dr Michael Hoffmeister

  68. Expression of oestrogen receptor β and prognosis of colorectal cancer

    Article • British Journal of Cancer, July 2012, Nature

    Dr Michael Hoffmeister

  69. Risk of Colorectal Cancer After Detection and Removal of Adenomas at Colonoscopy: Population-Based Case-Control Study

    Article • Journal of Clinical Oncology, July 2012, American Society of Clinical Oncology (ASCO)

    Dr Michael Hoffmeister

  70. Copy number variations of GSTT1 and GSTM1, colorectal cancer risk and possible effect modification of cigarette smoking and menopausal hormone therapy

    Article • International Journal of Cancer, May 2012, Wiley

    Dr Michael Hoffmeister

  71. Beta blocker use and colorectal cancer risk

    Article • Cancer, May 2012, Wiley

    Dr Michael Hoffmeister

  72. Effect of Type 2 Diabetes Predisposing Genetic Variants on Colorectal Cancer Risk

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2012, Endocrine Society

    Dr Michael Hoffmeister

  73. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals

    Article • Gut, April 2012, BMJ

    Dr Michael Hoffmeister

  74. A Comprehensive Investigation on Common Polymorphisms in the MDR1/ABCB1 Transporter Gene and Susceptibility to Colorectal Cancer

    Article • PLoS ONE, March 2012, PLOS

    Dr Michael Hoffmeister

  75. Characterization of Gene-Environment Interactions for Colorectal Cancer Susceptibility Loci

    Article • Cancer Research, February 2012, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  76. Helicobacter pylori Infection and Colorectal Cancer Risk: Evidence From a Large Population-based Case-Control Study in Germany

    Article • American Journal of Epidemiology, January 2012, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  77. Sex-Specific Prevalence of Adenomas and Colorectal Cancer

    Article • JAMA, January 2012, American Medical Association (AMA)

    Dr Michael Hoffmeister

  78. Shared ancestral susceptibility to colorectal cancer and other nutrition related diseases

    Article • BMC Medical Genetics, January 2012, Springer Science + Business Media

    Dr Michael Hoffmeister

  79. Interval cancers after negative colonoscopy: population-based case-control study

    Article • Gut, December 2011, BMJ

    Dr Michael Hoffmeister

  80. Age-Specific Administration of Chemotherapy and Long-Term Quality of Life in Stage II and III Colorectal Cancer Patients: A Population-Based Prospective Cohort

    Article • The Oncologist, November 2011, Alphamed Press

    Dr Michael Hoffmeister

  81. Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database

    Article • American Journal of Epidemiology, October 2011, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  82. Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants, and associations with quality of life

    Article • British Journal of Cancer, August 2011, Nature

    Dr Michael Hoffmeister

  83. Long-Term Risk of Colorectal Cancer After Negative Colonoscopy

    Article • Journal of Clinical Oncology, August 2011, American Society of Clinical Oncology (ASCO)

    Dr Michael Hoffmeister

  84. Reply

    Article • Gastroenterology, July 2011, Elsevier

    Dr Michael Hoffmeister

  85. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes

    Article • April 2011

    Dr Michael Hoffmeister

  86. Clotting Factor Gene Polymorphisms and Colorectal Cancer Risk

    Article • Journal of Clinical Oncology, March 2011, American Society of Clinical Oncology (ASCO)

    Dr Michael Hoffmeister

  87. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk

    Article • February 2011

    Dr Michael Hoffmeister

  88. Protection From Colorectal Cancer After Colonoscopy

    Article • Annals of Internal Medicine, January 2011, American College of Physicians

    Dr Michael Hoffmeister

  89. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk

    Article • Carcinogenesis, November 2010, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  90. Estimated long-term effects of the initial 6 years of the German screening colonoscopy program

    Article • Gastrointestinal Endoscopy, October 2010, Elsevier

    Dr Michael Hoffmeister

  91. Male Sex and Smoking Have a Larger Impact on the Prevalence of Colorectal Neoplasia Than Family History of Colorectal Cancer

    Article • Clinical Gastroenterology and Hepatology, October 2010, Elsevier

    Dr Michael Hoffmeister

  92. Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility

    Article • Carcinogenesis, July 2010, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  93. Response: Re: Protection From Right- and Left-Sided Colorectal Neoplasms After Colonoscopy: Population-Based Study

    Article • JNCI Journal of the National Cancer Institute, June 2010, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  94. Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer

    Article • Carcinogenesis, April 2010, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  95. Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk

    Article • International Journal of Cancer, March 2010, Wiley

    Dr Michael Hoffmeister

  96. Low Risk of Colorectal Cancer and Advanced Adenomas More Than 10 Years After Negative Colonoscopy

    Article • Gastroenterology, March 2010, Elsevier

    Dr Michael Hoffmeister

  97. Genetic polymorphisms inGSTgenes and survival of colorectal cancer patients treated with chemotherapy

    Article • Pharmacogenomics, January 2010, Future Medicine

    Dr Michael Hoffmeister

  98. Protection From Right- and Left-Sided Colorectal Neoplasms After Colonoscopy: Population-Based Study

    Article • JNCI Journal of the National Cancer Institute, December 2009, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  99. Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM

    Article • Carcinogenesis, November 2009, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  100. Effect Modification by Smoking on the Association between Genetic Polymorphisms in Oxidative Stress Genes and Colorectal Cancer Risk

    Article • Cancer Epidemiology Biomarkers & Prevention, July 2009, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  101. No Evidence for Variation in Colorectal Cancer Risk Associated With Different Types of Postmenopausal Hormone Therapy

    Article • Clinical Pharmacology & Therapeutics, July 2009, Nature

    Dr Michael Hoffmeister

  102. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: Estimates based on 1,875,708 screening colonoscopies

    Article • European Journal of Cancer, July 2009, Elsevier

    Dr Michael Hoffmeister

  103. Exposure to environmental tobacco smoke and the risk of colorectal cancer in a case–control study from Germany

    Article • European Journal of Cancer Prevention, February 2009, Wolters Kluwer Health

    Dr Michael Hoffmeister

  104. Genetic Polymorphisms in Genes Related to Oxidative Stress (GSTP1, GSTM1, GSTT1, CAT, MnSOD, MPO, eNOS) and Survival of Rectal Cancer Patients after Radiotherapy

    Article • Journal of Cancer Epidemiology, January 2009, Hindawi Publishing Corporation

    Dr Michael Hoffmeister

  105. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer

    Article • Nature Genetics, November 2008, Nature

    Dr Michael Hoffmeister

  106. Family History and Age at Initiation of Colorectal Cancer Screening

    Article • The American Journal of Gastroenterology, September 2008, Nature

    Dr Michael Hoffmeister

  107. Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology

    Article • British Journal of Cancer, July 2008, Nature

    Dr Michael Hoffmeister

  108. Welche Voraussetzungen sind für ein Screening notwendig?

    Article • Der Internist, April 2008, Springer Science + Business Media

    Dr Michael Hoffmeister

  109. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis

    Article • International Journal of Cancer, January 2008, Wiley

    Dr Michael Hoffmeister

  110. Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany

    Article • British Journal of Cancer, November 2007, Nature

    Dr Michael Hoffmeister

  111. The functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk

    Article • Carcinogenesis, August 2007, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  112. Case-Control Study Supports Extension of Surveillance Interval After Colonoscopic Polypectomy to at Least 5 Yr

    Article • The American Journal of Gastroenterology, August 2007, Nature

    Dr Michael Hoffmeister

  113. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene???environment interaction?

    Article • Pharmacogenetics and Genomics, August 2007, Wolters Kluwer Health

    Dr Michael Hoffmeister

  114. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies

    Article • Gut, June 2007, BMJ

    Dr Michael Hoffmeister

  115. Validity of Self-Reported Endoscopies of the Large Bowel and Implications for Estimates of Colorectal Cancer Risk

    Article • American Journal of Epidemiology, June 2007, Oxford University Press (OUP)

    Dr Michael Hoffmeister

  116. Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: Evidence from a case-control study in Germany

    Article • European Journal of Cancer, May 2007, Elsevier

    Dr Michael Hoffmeister

  117. Potential for Colorectal Cancer Prevention of Sigmoidoscopy Versus Colonoscopy: Population-Based Case Control Study

    Article • Cancer Epidemiology Biomarkers & Prevention, March 2007, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  118. Gender differences in colorectal cancer: implications for age at initiation of screening

    Article • British Journal of Cancer, February 2007, Nature

    Dr Michael Hoffmeister, Volker Arndt

  119. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: A population-based case–control study

    Article • International Journal of Cancer, January 2007, Wiley

    Dr Michael Hoffmeister

  120. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer

    Article • Cancer Detection and Prevention, January 2007, Elsevier

    Dr Michael Hoffmeister

  121. ARLTS1 variants and risk of colorectal cancer

    Article • Cancer Letters, December 2006, Elsevier

    Dr Michael Hoffmeister

  122. Death Receptor 4 Variants and Colorectal Cancer Risk

    Article • Cancer Epidemiology Biomarkers & Prevention, October 2006, American Association for Cancer Research (AACR)

    Dr Michael Hoffmeister

  123. Cigarette smoking and colorectal cancer risk in Germany: A population-based case–control study

    Article • International Journal of Cancer, August 2006, Wiley

    Dr Michael Hoffmeister

  124. Do Older Adults Using NSAIDs Have a Reduced Risk of Colorectal Cancer?

    Article • Drugs & Aging, January 2006, Springer Science + Business Media

    Dr Michael Hoffmeister

  125. SULT1A1 genotype and susceptibility to colorectal cancer

    Article • International Journal of Cancer, January 2006, Wiley

    Dr Michael Hoffmeister